OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Chief Executive Officer at Burrill & Company
Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.
Life-sciences companies continue upward momentum in 2014.
Frenzy cools as investors seeking a quick return turn elsewhere.
Early-stage companies are now embraced by buyers of new issues.